학술논문
Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial
Document Type
Article
Author
Wu, Xiaohua; Zhu, Jianqing; Yin, Rutie; Yang, Jiaxin; Liu, Jihong; Wang, Jing; Wu, Lingying; Liu, Ziling; Gao, Yunong; Wang, Danbo; Lou, Ge; Yang, Hongying; Zhou, Qi; Kong, Beihua; Huang, Yi; Chen, Lipai; Li, Guiling; An, Ruifang; Wang, Ke; Zhang, Yu; Yan, Xiaojian; Lu, Xin; Lu, Weiguo; Hao, Min; Wang, Li; Cui, Heng; Chen, Qionghua; Abulizi, Guzhalinuer; Huang, Xianghua; Tian, Xiaofei; Wen, Hao; Huang, Zhao; Dong, Juan; Zhang, Charlie; Hou, Jianmei; Mirza, Mansoor R.
Source
In eClinicalMedicine June 2024 72
Subject
Language
ISSN
2589-5370